Sculptor Capital LP Zynerba Pharmaceuticals, Inc. Transaction History

Sculptor Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	BUY	$3.31 - $6.54 $10,923 - $21,582	3,300 Added 4.19%	82,100 $0
Q1 2020 May 14, 2020	SELL	$2.9 - $6.16 $420,500 - $893,200	-145,000 Reduced 64.79%	78,800 $0
Q3 2019 Nov 14, 2019	BUY	$7.56 - $15.44 $1.01 Million - $2.07 Million	134,100 Added 149.5%	223,800 $0
Q1 2019 May 13, 2019	BUY	$3.6 - $6.22 $264,240 - $456,548	73,400 Added 450.31%	89,700 $0
Q2 2018 Aug 13, 2018	SELL	$7.98 - $12.39 $23,142 - $35,931	-2,900 Reduced 15.1%	16,300 $159,000
Q3 2017 Nov 13, 2017	BUY	$5.73 - $9.44 $110,016 - $181,248	19,200	19,200 $0

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.